1Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol, 2001, 166: 6-18.
2Li QL, Guan HW, Zhang QP, et al. Multicentricity and its associated factors in renal cell carcinoma. Chin Med J, 2002, 115:1341-1344.
3Morell-Quadreny L, Clar-Blanch F, Fenollosa-Enterna B, et al. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma. Anticancer Res, 1998, 18: 677-682.
4Hafez KS, Novick AC, Campbell SC. Patterns of tumor recurrence and guidelines for follow up after nephron sparing surgery for sporadic renal cell carcinoma. J Urol, 1997,157: 2067-2070.
5Novick AC,Streem SB. Surgery of the kidney. In: Walsh PC, Retik AB, Vaughan ED, et al, eds. Campbell′s Urology. Vol 3. 7th ed. Philadelphia: Harcourt Publisher Limited, 1998.2973-3061.
6Stephens R, Graham SD Jr. Enucleation of tumor versus partial nephrectomy as conservative treatment of renal cell carcinoma. Cancer, 1990,65:2663-2667.
7Blackley SK, Ladaga L, Woolfitt RA, et al. Ex situ study of the effectiveness of enucleation in patients with renal cell carcinoma. J Urol, 1988,140: 6-10.
8Schlichter A, Schubert R, Werner W, et al. How accurate is diagnostic imaging in determination of size and multifocality of renal cell carcinoma as a prerequisite for nephron-sparing surgery? Urol Int, 2000, 64:192-197.